EDMONTON, Alberta, Nov.  07, 2022  (GLOBE NEWSWIRE) -- Ceapro Inc.  (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients and disruptive technologies for healthcare and cosmetic industries, announced today the signing of a license agreement with The Governors of the University of Alberta to use designated areas within Agri-Food Discovery Place (AFDP) to further scale up the Company’s disruptive Pressurized Gas eXpanded (PGX) technology in preparation for commercial partnerships.
Ceapro Inc. Launches Next Phase of Scale Up for its Disruptive PGX Technology to Pursue Product Development for Nutraceutical and Pharmaceutical Markets
Ceapro Inc. Launches Next Phase of Scale Up for its Disruptive PGX Technology to Pursue Product Development for Nutraceutical and Pharmaceutical Markets --  Ceapro Inc.  (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients and disruptive technologies for healthcare and cosmetic industries, announced today the signing of a license agreement with The Governors of the University of Alberta to use designated areas within Agri-Food Discovery Place (AFDP) to further scale up the Company’s disruptive Pressurized Gas eXpanded (PGX) technology in preparation for commercial partnerships.